Poniard Pharmaceuticals (PARD) Stock Chart & Stock Price History Add Compare Share Share Chart Stock AnalysisChartBuy This Stock Poniard Pharmaceuticals Stock Price Performance The Poniard Pharmaceuticals (PARD) stock chart highlights key performance trends across multiple timeframes. In the past month, the stock has decreased 100.00%, reflecting recent market activity.Five years ago, the stock traded at $0.05, representing a 100.00% decrease over that period. At the time, it had a market cap of and a volume of 50 shares. Receive PARD Stock News and Ratings via EmailSign-up to receive the latest news and ratings for Poniard Pharmaceuticals and its competitors with MarketBeat's FREE daily newsletter. Email Address 1 Month Performance-100.00%3 Month PerformanceN/A5 Year Performance-100.00% PARD Stock Chart for Saturday, August, 2, 2025 PARD Chart by TradingView Poniard Pharmaceuticals Stock Price History Daily Weekly Monthly Yearly Time Frame Custom Range 1 Month 3 Months 6 Months Year-to-Date 1 Year 3 Year 5 Year Time Frame Start Date End Date Export to Excel DateOpening PriceClosing PriceHighLowVolumeMarket Capitalization07/04/2025$0.00$0.00$0.00$0.002,479 shs$0.0007/03/2025$0.00$0.00$0.00$0.002,479 shs$0.0007/02/2025$0.00$0.00$0.00$0.002,479 shs$0.0007/01/2025$0.00$0.00$0.00$0.002,479 shs$0.00 Related Companies 180 Life Sciences Stock Price Chart 4D pharma Stock Price Chart 4Front Ventures Stock Price Chart Abattis Bioceuticals Stock Price Chart Abcam Stock Price Chart Acusphere Stock Price Chart ADHERA THERAPEUTICS Stock Price Chart Aeolus Pharmaceuticals Stock Price Chart Aesther Healthcare Acquisition Stock Price Chart Agentix Stock Price Chart Receive PARD Stock News and Ratings via EmailSign-up to receive the latest news and ratings for Poniard Pharmaceuticals and its competitors with MarketBeat's FREE daily newsletter. This page (OTCMKTS:PARD) was last updated on 8/2/2025 by MarketBeat.com Staff From Our PartnersElon’s Secret Social Security BombshellTo All Americans Born Before April 16th, 1963: Did Trump Just Give The Green Light To Radically RE-DO Social S...Banyan Hill Publishing | SponsoredIs Elon's empire crumbling?The Tesla Shock Nobody Sees Coming While headlines scream "Tesla is doomed"... Jeff Brown has uncovered ...Brownstone Research | SponsoredMan Who Called Nvidia at $1.10 Says Buy This Now...In 2004, one man called Nvidia before just about anyone knew it existed. Now, this same guy says a new comp...The Oxford Club | SponsoredWhy AMZN, GOOG, MSFT might destroy NVDAInvesting Legend Hints the End May be Near for These 3 Iconic Stocks Futurist Eric Fry say Amazon, Tesla an...InvestorPlace | SponsoredJeff Bezos Launches "ChatGPT Killer"?Amazon just launched Nova—its secretive new AI system designed to rival ChatGPT. Bezos says he now spends 95% ...Stansberry Research | SponsoredAlien rocks potentially worth trillions…It might look like just a weird rock—but it’s tied to a discovery 60 Minutes says could be worth up to $16 tri...Porter & Company | Sponsored[No Brainer Gold Play]: “Show me a better investment.”A Historic Gold Announcement Is About to Rock Wall Street? For months, sharp-eyed analysts have watched the...Golden Portfolio | SponsoredToo busy to trade? Good.Too busy to trade? That might be your edge. This after-hours strategy is built for people who don’t sit at ...Timothy Sykes | Sponsored Adding Choose a watchlist: Watchlist Adding You have already added ten stocks to your watchlist. Upgrade to MarketBeat All Access to add more stocks to your watchlist. Adding Poniard Pharmaceuticals Inc. Please log in to your account or sign up in order to add this asset to your watchlist. Share Poniard Pharmaceuticals With A Colleague Link copied to clipboard. Get 30 Days of MarketBeat All Access for Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools. Start Your 30-Day Trial MarketBeat All Access Features Best-in-Class Portfolio Monitoring Get personalized stock ideas. Compare portfolio to indices. Check stock news, ratings, SEC filings, and more. Stock Ideas and Recommendations See daily stock ideas from top analysts. Receive short-term trading ideas from MarketBeat. Identify trending stocks on social media. Advanced Stock Screeners and Research Tools Use our seven stock screeners to find suitable stocks. Stay informed with MarketBeat's real-time news. Export data to Excel for personal analysis. Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required Log In or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
